Both in Biotechnology
Scribe Therapeutics vs Lineage Cell Therapeutics
Over the past year SCTX returned −47.7% and LCTX returned 0.0%; their daily moves had a correlation of 0.13.
SCTX −47.7% LCTX 0.0%Growth of $1, one year, split-adjusted
| Metric | SCTX | LCTX |
|---|---|---|
| Price | $15.54 | $1.01 |
| Market cap | $294.2M | $255.4M |
| Today | +0.78% | +1.00% |
| 1 month | −7.4% | +8.6% |
| 6 months | — | −28.9% |
| Year to date | — | −39.5% |
| 1 year | — | −45.1% |
| Revenue growth (YoY) | — | −61.3% |
| Gross margin | — | 100.0% |
| Net margin | — | 138.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.5× |
| Net cash | — | $50.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 52.7% |
| Short % of float | 14.6% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).